The pathophysiological mechanism underlying the edema formation is shared between HAE and AAE: insufficient C1-inhibitor activity leads to uncontrolled kallikrein activation, with subsequent overproduction of bradykinin. This evidence concerns the gene KLK4 and acquired angioedema.